Markku Lähteenvuo

35PUBLICATIONS
80CO-AUTHORS
Clinical neuropsychologyToxicology (incl. clinical toxicology)PharmacogenomicsLiquid biopsiesVictims
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 19, 2026
Incident low-dose quetiapine use in adults newly diagnosed with depression in primary care: A nationwide register-based study.

|Aug 12, 2026
Real-world effectiveness of psychiatric pharmacotherapies in reducing the risk of substance use- and psychiatric hospitalisations in cannabis use disorder - an exploratory nationwide register-based study.

|Jun 22, 2026
Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.

|Apr 09, 2026
Comparative Clinical Trajectories Across Cannabis-Related and Nonsubstance-Related Psychoses.

Antti Mustonen, Solja Niemelä, Alexander Denissoff

|Mar 21, 2026
Systematic review of stranger homicides by psychotic individuals.

Jenna Räsänen, Ilkka Ojansuu, Jari Tiihonen

|Oct 23, 2025
Relapse risk prediction in patients with first-episode bipolar disorder: development, external validation, and pharmacotherapy associations of a machine learning model.

Johannes Lieslehto, Jari Tiihonen, Markku Lähteenvuo

Pageof 6

Frequent Collaborators

18 joint publications

Jari Tiihonen

10 joint publications

Jaana Suvisaari

7 joint publications

Kimmo Suokas

6 joint publications

Heidi Taipale